KARYOPHARM THERAPEUTICS INC's ticker is KPTI and the CUSIP is 48576U106. A total of 129 filers reported holding KARYOPHARM THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.44 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,544 | -22.1% | 1,152,298 | +4.2% | 0.00% | 0.0% |
| Q2 2023 | $1,982 | -82.1% | 1,106,361 | -61.1% | 0.00% | -80.0% |
| Q1 2023 | $11,077 | +211.3% | 2,847,389 | +172.0% | 0.01% | +150.0% |
| Q4 2022 | $3,558 | -99.9% | 1,046,712 | +129.8% | 0.00% | -33.3% |
| Q3 2022 | $2,487,000 | +574.0% | 455,464 | +456.0% | 0.00% | – |
| Q2 2022 | $369,000 | -42.9% | 81,925 | -6.6% | 0.00% | -100.0% |
| Q1 2022 | $646,000 | -72.4% | 87,724 | -75.9% | 0.00% | – |
| Q4 2021 | $2,338,000 | +203.6% | 363,504 | +174.6% | 0.00% | – |
| Q3 2021 | $770,000 | -62.5% | 132,389 | -33.4% | 0.00% | -100.0% |
| Q2 2021 | $2,052,000 | -28.9% | 198,775 | -27.6% | 0.00% | -50.0% |
| Q1 2021 | $2,887,000 | -19.1% | 274,374 | +19.1% | 0.00% | 0.0% |
| Q4 2020 | $3,569,000 | +357.0% | 230,465 | +330.8% | 0.00% | – |
| Q3 2020 | $781,000 | -42.7% | 53,492 | -25.7% | 0.00% | -100.0% |
| Q2 2020 | $1,364,000 | +18.5% | 72,015 | +20.2% | 0.00% | 0.0% |
| Q1 2020 | $1,151,000 | -31.2% | 59,937 | -31.4% | 0.00% | 0.0% |
| Q4 2019 | $1,674,000 | +399.7% | 87,347 | +151.0% | 0.00% | – |
| Q3 2019 | $335,000 | +24.1% | 34,802 | -22.9% | 0.00% | – |
| Q2 2019 | $270,000 | +110.9% | 45,153 | +105.4% | 0.00% | – |
| Q1 2019 | $128,000 | +39.1% | 21,985 | +122.9% | 0.00% | – |
| Q4 2018 | $92,000 | -91.7% | 9,864 | -84.8% | 0.00% | -100.0% |
| Q3 2018 | $1,105,000 | +140.7% | 64,887 | +139.9% | 0.00% | – |
| Q2 2018 | $459,000 | -20.5% | 27,045 | -37.1% | 0.00% | – |
| Q1 2018 | $577,000 | +111.4% | 42,985 | +50.7% | 0.00% | – |
| Q4 2017 | $273,000 | +245.6% | 28,526 | +298.6% | 0.00% | – |
| Q3 2017 | $79,000 | -92.0% | 7,157 | -93.4% | 0.00% | – |
| Q2 2017 | $983,000 | +391.5% | 108,600 | +593.7% | 0.00% | – |
| Q1 2017 | $200,000 | +239.0% | 15,656 | +149.9% | 0.00% | – |
| Q4 2016 | $59,000 | +37.2% | 6,266 | +41.4% | 0.00% | – |
| Q3 2016 | $43,000 | +975.0% | 4,431 | +748.9% | 0.00% | – |
| Q2 2016 | $4,000 | +300.0% | 522 | +135.1% | 0.00% | – |
| Q1 2016 | $1,000 | -85.7% | 222 | -57.1% | 0.00% | – |
| Q4 2015 | $7,000 | -93.9% | 518 | -95.5% | 0.00% | – |
| Q3 2015 | $115,000 | +721.4% | 11,591 | +2181.7% | 0.00% | – |
| Q2 2015 | $14,000 | -79.4% | 508 | -77.6% | 0.00% | – |
| Q1 2015 | $68,000 | +65.9% | 2,268 | +105.8% | 0.00% | – |
| Q4 2014 | $41,000 | +156.2% | 1,102 | +134.5% | 0.00% | – |
| Q3 2014 | $16,000 | +45.5% | 470 | +99.2% | 0.00% | – |
| Q2 2014 | $11,000 | +22.2% | 236 | -21.6% | 0.00% | – |
| Q1 2014 | $9,000 | +350.0% | 301 | +144.7% | 0.00% | – |
| Q4 2013 | $2,000 | – | 123 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Delphi Management Partners VIII, L.L.C. | 2,263,006 | $35,031,000 | 23.03% |
| Palo Alto Investors LP | 5,267,652 | $81,543,000 | 4.28% |
| Fairmount Funds Management LLC | 702,351 | $10,872,000 | 3.89% |
| Birchview Capital, LP | 188,000 | $2,910,000 | 1.68% |
| Mesirow Financial Investment Management, Inc. | 22,303 | $345,250,000 | 1.09% |
| EMERALD ADVISERS, LLC | 1,822,781 | $28,217,000 | 0.94% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 1,661,236 | $25,716,000 | 0.90% |
| RICE HALL JAMES & ASSOCIATES, LLC | 1,552,504 | $24,033,000 | 0.85% |
| Altium Capital Management LP | 133,951 | $2,074,000 | 0.77% |
| Hood River Capital Management LLC | 931,754 | $14,424,000 | 0.48% |